Back to Search
DAVID GINGRICH, MD
MD
Emergency Medicine Physician
NPI: 1881749448Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MD028277E(PA)
Research & Publications (8)
Synthesis, modeling, and in vitro activity of (3'S)-epi-K-252a analogues. Elucidating the stereochemical requirements of the 3'-sugar alcohol on trkA tyrosine kinase activity.
PMID 15916429·J Med Chem·2005
7-preclinical
A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055.
PMID 14640546·J Med Chem·2003
7-preclinical
Synthesis and kinase inhibitory activity of 3'-(S)-epi-K-252a.
PMID 12270156·Bioorg Med Chem Lett·2002
8-other
OSETI with STACEE: a search for nanosecond optical transients from nearby stars.
PMID 19413506·Astrobiology·2009
8-other
Rapid variable-number tandem-repeat genotyping for Mycobacterium leprae clinical specimens.
PMID 19386839·J Clin Microbiol·2009
4-observational
Tobacco world: evaluation of a tobacco cessation training program for third-year medical students.
PMID 18820494·Acad Med·2008
8-other
Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy.
PMID 15032727·Curr Med Chem·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 24 CREE DR
LOCK HAVEN, PA 17745 - Phone
- (570) 893-5000
Quick Facts
- NPI
- 1881749448
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile